The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.94
Bid: 3.72
Ask: 4.30
Change: 0.47 (13.54%)
Spread: 0.58 (15.591%)
Open: 3.64
High: 4.00
Low: 3.64
Prev. Close: 3.47
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Product Regulatory Approval In Brazil

18 Aug 2023 07:00

RNS Number : 7053J
Plant Health Care PLC
18 August 2023
 

18 August, 2023

 

PLANT HEALTH CARE plc

("Plant Health Care" or the "Company")

 

Brazil approves PHC279 to Control Diseases of Sugar Cane and Coffee

 

Plant Health Care® (AIM: PHC.L), a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to announce that its biochemical fungicide, PHC279, for the control of sugar cane and coffee disease has received federal approval in Brazil.

Brazil is the world's largest producer of sugar cane and coffee. In the 2023/24 season, the area planted with sugar cane in Brazil is forecast to be 9.8 million hectares and more than 2.5 million hectares for coffee. In the 2021/22 season, Brazilian farmers spent more than US$46m on the control of sugar cane diseases and more than US$127m on the control of coffee diseases. PHC279 was submitted for regulatory approval in December 2022 as a foliar-applied product for the control of sugar cane orange rust (Puccinia kuehnii) and coffee leaf rust (Hemileia vastatrix). PHC279 is the active ingredient in the Company's product Saori®, which is successfully being used in Brazil as a seed treatment for the control of soybean diseases.

 

PHC279 originates from the Company's PREtec technology platform (Vaccines for PlantsTM). Derived from natural proteins, PREtec is an environmentally friendly technology which stimulates crop growth, enhances the ability to withstand a variety of abiotic stresses, improves disease control, plant health and yield. The environmentally friendly profile and unique mode of action of PHC279 is expected to lead to its wide adoption by Brazilian sugar cane and coffee growers. The Company is currently in discussions with potential distribution partners in anticipation of product launch during 2024.

 

The regulatory process in Brazil for agricultural products involves detailed review and approval by three government agencies. The Ministry of Agriculture establishes a product's agronomic recommendations; the National Health Surveillance Agency checks for safety, while the Brazilian Institute of Environment and Renewable Natural Resources classifies the environmental hazard profile of the product, to ensure its use does not pose a threat to the environment. PHC279 passed through this process with approval from all three agencies in less than a year, confirming the Brazilian government's commitment to promoting effective and environmentally friendly products.

 

Plant Health Care continues to scale in markets around the world and is growing its relationships with major global distribution partners. The Company is on track to achieve revenue of $30 million by 2025 through the launch of new products and organic business growth through current and future distributor relationships.

 

Jeff Tweedy, CEO of Plant Health Care, said: ‟Building on the success of Saori use in soybeans and the continued growth of H2Copla use in sugar cane, this new registration will bring the benefits of PHC279 to sugar cane and coffee growers and expand Plant Health Care's current business in Brazil. This product will help Brazilian farmers sustainably produce crops and supports the Company's vision to be a leading global provider of peptides for agricultural production."

 

For further information, please contact: 

 Plant Health Care plc  Jeff Tweedy, CEO

 

+1 919 926 1600

 Cenkos Securities plc - Nomad & Broker  Neil McDonald / Pete Lynch

 

+44 (0) 131 220 9771

 SEC Newgate (Financial Communications)  Robin Tozer / Harry Handyside / George Esmond

+44 (0)7540 106 366 phc@secnewgate.co.uk

 

About Plant Health Care

Plant Health Care offers products to improve the health, vigour and yield of major field crops such as corn, soybeans, potatoes and rice, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors and supply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favourable environmental profile. 

 

Find out more at www.planthealthcare.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
REAGPUGURUPWGBM
Date   Source Headline
19th Dec 20164:35 pmRNSPrice Monitoring Extension
14th Dec 20164:40 pmRNSSecond Price Monitoring Extn
14th Dec 20164:35 pmRNSPrice Monitoring Extension
14th Dec 20167:00 amRNSNew Commercial Distribution Agreements
30th Nov 20167:00 amRNSDirectorate Change
17th Oct 20167:00 amRNSDirectorate Change
14th Sep 20167:00 amRNSHalf-year Report
31st Aug 20164:30 pmRNSTotal Voting Rights
23rd Aug 20162:54 pmRNSHolding(s) in Company
23rd Aug 20167:00 amRNSDirector/PDMR Shareholding
23rd Aug 20167:00 amRNSBlock listing Interim Review
22nd Aug 20163:44 pmRNSHolding(s) in Company
22nd Aug 20163:38 pmRNSHolding(s) in Company
16th Aug 201611:41 amRNSResult of General Meeting, Placing & Open Offer
29th Jul 20167:00 amRNSProposed Placing, Subscription and Open Offer
7th Jun 20167:00 amRNSProgress on New Technology Builds Momentum
23rd May 20163:09 pmRNSResult of AGM
17th May 20163:45 pmRNSChange of Registered Office Address
25th Apr 20167:00 amRNSAnnual Financial Report
8th Apr 20167:00 amRNSAnnual Financial Report
22nd Feb 20167:00 amRNSBlocklisting Interim Review
2nd Feb 20167:00 amRNSReduced Disclosure Framework
29th Jan 20167:00 amRNSTrading Statement
2nd Dec 20157:00 amRNSPHC Expands Distribution Agreement with Sym-Agro
1st Dec 20157:00 amRNSPHC notification of major interest in shares
30th Nov 20157:00 amRNSPHC and Arysta LifeScience Terminate Agreement
30th Oct 20151:21 pmRNSTotal Voting Rights
30th Sep 20153:47 pmRNSTotal Voting Rights
25th Sep 20157:00 amRNSRe Agreement
14th Sep 20157:00 amRNSHalf Yearly Report
19th Aug 20157:00 amRNSBlocklisting Interim Review
13th Jul 20157:00 amRNSPHC Granted Product Registration in Brazil
18th Jun 20157:00 amRNSDirector/PDMR Shareholding
17th Jun 20152:20 pmRNSResult of AGM
2nd Jun 20157:00 amRNSRe Agreement
6th May 20157:01 amRNSPlant Health Care Hires Jeff Tweedy
30th Apr 20153:02 pmRNSTotal Voting Rights
22nd Apr 20153:05 pmRNSTR1: Notificiation of Major Interest in Shares
17th Apr 20157:00 amRNSDIRECTORS' DEALING
15th Apr 20157:00 amRNSAnnual Report 2014 and Notice of AGM
8th Apr 20157:00 amRNSRe Agreement
30th Mar 20157:00 amRNSAnnual Financial Report
27th Mar 20157:00 amRNSDirectorate Change
5th Mar 201512:30 pmRNSPlant Health Care signs Distribution Agreement
20th Feb 20155:48 pmRNSBlocklisting Interim Review
17th Feb 20154:03 pmRNSHolding(s) in Company
30th Jan 20157:00 amRNSBoard changes and trading update
15th Dec 20141:51 pmRNSTR-1: Notification of Major Interest in Shares
5th Dec 20147:00 amRNSPHC Signs Agreement With Arysta LifeScience
19th Nov 20147:00 amRNSPlant Health Care Hires LHA

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.